Small Cell Lung Cancer

Showing NaN - NaN of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Small Cell Lung Cancer Trial in Worldwide (biological, drug, radiation)

Recruiting
  • Small Cell Lung Cancer
  • Pembrolizumab 200 mg
  • +8 more
  • Chandler, Arizona
  • +170 more
Feb 2, 2023

Small Cell Lung Cancer Trial in Worldwide (Pembrolizumab, MK-4830, MK-5890)

Recruiting
  • Small Cell Lung Cancer
  • Pembrolizumab
  • +6 more
  • Gilbert, Arizona
  • +48 more
Jan 19, 2023

Small Cell Lung Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Carboplatin)

Active, not recruiting
  • Small Cell Lung Cancer
  • Lone Tree, Colorado
  • +123 more
Dec 21, 2022

Small Cell Lung Cancer, NSCLC, Squamous, NSCLC, Non-squamous Trial in Worldwide (ladiratuzumab vedotin)

Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • Chandler, Arizona
  • +65 more
Dec 19, 2022

Small Cell Lung Cancer Trial in Worldwide (Irinotecan liposome injection, Topotecan)

Active, not recruiting
  • Small Cell Lung Cancer
  • Denver, Colorado
  • +117 more
Nov 22, 2022

Small Cell Lung Cancer Trial in Seoul (Durvalumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Nov 6, 2022

Small Cell Lung Cancer Trial in Worldwide (ABBV-011, Budigalimab)

Recruiting
  • Small Cell Lung Cancer
  • Birmingham, Alabama
  • +32 more
Oct 5, 2022

Small Cell Lung Cancer Trial in Worldwide (BMS-986012 (anti-fucosyl-GM1), Nivolumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • BMS-986012 (anti-fucosyl-GM1)
  • Nivolumab
  • New York, New York
  • +15 more
Sep 28, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Small Cell Lung Cancer Trial in Worldwide (Venetoclax, Atezolizumab, Carboplatin)

Terminated
  • Small Cell Lung Cancer
  • Atlanta, Georgia
  • +4 more
Oct 8, 2021

Advanced Solid Tumours, Small Cell Lung Cancer Trial in Australia, Korea, Republic of, Taiwan (IMP4297)

Recruiting
  • Advanced Solid Tumours
  • Small Cell Lung Cancer
  • Albury, New South Wales, Australia
  • +12 more
Aug 10, 2021

Small Cell Lung Cancer Trial in Worldwide (LY3295668 Erbumine)

Completed
  • Small Cell Lung Cancer
  • LY3295668 Erbumine
  • Fayetteville, Arkansas
  • +39 more
Jul 30, 2021

Small Cell Lung Cancer Trial in Worldwide (Placebo for dexamethasone, Placebo for rovalpituzumab tesirine, Rovalpituzumab

Terminated
  • Small Cell Lung Cancer
  • Placebo for dexamethasone
  • +3 more
  • Huntsville, Alabama
  • +307 more
Jul 28, 2021

Small Cell Lung Cancer Trial in Seoul (AZD1775)

Completed
  • Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Mar 18, 2021

Small Cell Lung Cancer Trial in Worldwide (Rovalpituzumab tesirine, Topotecan, Dexamethasone)

Completed
  • Small Cell Lung Cancer
  • Rovalpituzumab tesirine
  • +2 more
  • Huntsville, Alabama
  • +194 more
Feb 19, 2021

Small Cell Lung Cancer Trial in Seoul (Olaparib)

Completed
  • Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 16, 2021

Small Cell Lung Cancer Trial in Worldwide (Dinutuximab, Irinotecan, Topotecan)

Completed
  • Small Cell Lung Cancer
  • Dinutuximab
  • +2 more
  • Anchorage, Alaska
  • +225 more
Nov 12, 2020

Small Cell Lung Cancer Trial in Worldwide (Veliparib, Carboplatin, Etoposide)

Completed
  • Small Cell Lung Cancer
  • Scottsdale, Arizona
  • +61 more
May 4, 2020

Small Cell Lung Cancer Trial in Worldwide (Prexasertib)

Completed
  • Small Cell Lung Cancer
  • Fayetteville, Arkansas
  • +40 more
Mar 12, 2020

Small Cell Lung Cancer Trial in Seoul (Durvalumab)

Unknown status
  • Small Cell Lung Cancer
  • Seoul, MA, Korea, Republic of
    Samsung Medical Center
Feb 27, 2020

Small Cell Lung Cancer Trial in Seoul (pembrolizumab, paclitaxel)

Completed
  • Small Cell Lung Cancer
  • pembrolizumab, paclitaxel
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Feb 7, 2020

Small Cell Lung Cancer Trial in Korea, Republic of, Romania, United States (LY2523355, Granulocyte colony-stimulating factor

Completed
  • Small Cell Lung Cancer
  • LY2523355
  • Granulocyte colony-stimulating factor (G-CSF)
  • Torrington, Connecticut
  • +10 more
Sep 9, 2019

Small Cell Lung Cancer Trial in Korea, Republic of (Topotecan, Belotecan)

Completed
  • Small Cell Lung Cancer
  • Daegu, Korea, Republic of
  • +13 more
Dec 25, 2018

Small Cell Lung Cancer Trial in Seoul (AZD2811)

Terminated
  • Small Cell Lung Cancer
  • Seoul, Korea, Republic of
    Samsung Medical center
Nov 23, 2018